Qiagen Shares Surge on Reported Acquisition Interest from TPG and Bain Capital

Key Facts

1Qiagen shares gained following reports that private equity firms TPG and Bain Capital are interested in a potential takeover.

In a move reflecting growing private equity appetite for the healthcare sector, Qiagen shares rose following reports of interest from TPG and Bain Capital. According to reports, these firms are exploring a potential acquisition of the diagnostics and life sciences company, sparking market speculation regarding a competitive bidding process.

These developments come amid heightened interest in the diagnostics sector from major global market players. Per market data, QGEN shares closed at $42.90 on September 16, 2026, with the stock reaching a day high of $43.46 against a low of $42.56 during that session.

Traders should monitor for any official confirmations regarding takeover negotiations, with QGEN priced at $42.90 (close September 16, 2026). Based on the economic calendar, there are no immediate company-specific catalysts scheduled, leaving M&A sentiment as the primary driver for the stock's near-term performance.